BC Innovations | Jun 30, 2016
Distillery Therapeutics

Therapeutics: Meis homeobox 2 (MEIS2)

Cancer INDICATION: Acute myelogenous leukemia (AML) Patient sample and cell culture studies suggest inhibiting MEIS2 could help treat AML harboring the AML1-ETO oncogenic fusion protein . In AML1-ETO-positive patient samples, MEIS2 mRNA levels were higher than...
Items per page:
1 - 1 of 1